Contract Notice Detail
Summary Information
Summary Information
Base Total Price:
7,799,129.12 Euro
Request Reference:
838/2024
Request Name:
Ajuste direto para aquisição de Eculizumab [300 mg; sol inj; frs], para suprir necessidades na área da saúde
Phase:
Tendering Phase
State:
Awarded
Description:
Ajuste direto para aquisição de Eculizumab [300 mg; sol inj; frs], para suprir necessidades na área da saúde
Procedure Type:
VortalGOV - Direct Award (ECP)
Central Purchasing Bodies
Central Purchasing Bodies
Company Name
VAT
Location
Unidade Local de Saúde de Lisboa Ocidental, E. P. E.
507618319
Lisboa, PT
Unidade Local de Saúde de São João E.P.E.
509821197
Área Metropolitana do Porto, PT
Unidade Local Saúde de Braga, E.P.E.
515545180
Braga, PT
Unidade Local de Saude Amadora/Sintra, E.P.E.
503035416
Lisboa, PT
Unidade Local de Saúde de Santo António, E. P. E.
517392259
Área Metropolitana do Porto, PT
Unidade Local de Saúde de São José, E. P. E.
508080142
Lisboa, PT
Object of the Contract
Object of the Contract
Type of Contract:
Supplies Acquisition
Main Object CPV Main Category:
Avenida 5 de Outubro nº 125 1050-052 Lisboa Lisboa PORTUGAL
CPV Main Vocabulary
33600000-6 - Pharmaceutical products
CPV Supplementary Vocabulary
Additional Classifications List
Scheduling
Scheduling
Request online publishing date:
1/29/2024 9:39 AM
(UTC 0 hours)
Due datetime for receiving replies:
2/1/2024 6:00 PM
(UTC 0 hours)
Financial Settings
Financial Settings
Define Warranties?
Yes
Seriousness of the offer
Compliance
Yes
Stability and Quality of Works
% of contract value
2
Warranty Start Date
-
Warranty End Date
-
Extra-contractual civil liability
Yes
Warranty Value
Euro
Contract Documents
Contract Documents
Document Name
Description
Doc Classification
No items found...
Object of contract
This contract is subject to renewal?
No
The procurement is related to a project and/or programme financed by European Union funds?
No
Legal, economic, financial and technical information
The contract is reserved to sheltered workshops and economic operators aiming at the social and professional integration of disabled or disadvantaged persons?
No
Questionnaire
Questionnaire
Vision
1
Secção
1.1
Articulado da Consulta
Código
Descrição
Qt
Unidade
ECULIZUMAB [300 MG; SOL INJ; FRS]ECULIZUMAB [300 MG; SOL INJ; FRS]
2 284,00
UN
Totais
(Os valores mostrados não incluem IVA)
Evaluation
Evaluation
Vision
undefinedundefined
Public Messages
Public Messages
Type
Reference
Subject
Date
No items found...